VCYT vs. RBRK

Last updated Jul 11, 2026

VCYT (Veracyte, Inc.) and RBRK (Rubrik, Inc.) are both stocks. VCYT operates in Biotechnology (Healthcare), while RBRK operates in Software - Infrastructure (Technology). Over the past year, VCYT returned 110.38% vs -0.19% for RBRK. At a 0.26 correlation, their price movements are largely independent.

Performance

VCYT vs. RBRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Veracyte, Inc. (VCYT) and Rubrik, Inc. (RBRK). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VCYT achieves a 35.32% return, which is significantly higher than RBRK's 10.33% return.

VCYT

• 1D: -3.93%
• 1M: 20.14%
• 6M: 35.51%
• YTD: 35.32%
• 1Y: 110.38%
• 3Y*: 27.66%
• 5Y*: 8.45%
• 10Y*: 27.05%

RBRK

• 1D: -4.92%
• 1M: 23.74%
• 6M: 19.59%
• YTD: 10.33%
• 1Y: -0.19%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

VCYT vs. RBRK - Yearly Performance Comparison

	2026 (YTD)	2025	2024
VCYT Veracyte, Inc.	35.32%	6.31%	98.99%
RBRK Rubrik, Inc.	10.33%	17.01%	69.33%

Correlation

The correlation between VCYT and RBRK is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.26
Correlation (All Time) Calculated using the full available price history since Apr 25, 2024	0.26

Fundamentals

Market Cap VCYT : $4.55B RBRK : $17.37B
EPS VCYT : $1.09 RBRK : -$1.45
PS Ratio VCYT : 8.50 RBRK : 11.75
Total Revenue (TTM) VCYT : $541.74M RBRK : $1.42B
Gross Profit (TTM) VCYT : $386.89M RBRK : $1.15B
EBITDA (TTM) VCYT : $99.47M RBRK : -$275.30M

Return for Risk

VCYT vs. RBRK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VCYT

VCYT Risk / Return Rank: 87
VCYT Sharpe Ratio Rank: 89
VCYT Sortino Ratio Rank: 92
VCYT Omega Ratio Rank: 87
VCYT Calmar Ratio Rank: 85
VCYT Martin Ratio Rank: 82

RBRK

RBRK Risk / Return Rank: 44
RBRK Sharpe Ratio Rank: 44
RBRK Sortino Ratio Rank: 44
RBRK Omega Ratio Rank: 44
RBRK Calmar Ratio Rank: 44
RBRK Martin Ratio Rank: 44

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VCYT vs. RBRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Veracyte, Inc. (VCYT) and Rubrik, Inc. (RBRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VCYT	RBRK	Difference
Sharpe ratio: Return per unit of total volatility	1.76	-0.03	+1.79
Sortino ratio: Return per unit of downside risk	3.01	0.41	+2.60
Omega ratio: Gain probability vs. loss probability	1.33	1.05	+0.29
Calmar ratio: Return relative to maximum drawdown	2.74	-0.04	+2.78
Martin ratio: Return relative to average drawdown	6.00	-0.07	+6.07

VCYT vs. RBRK - Sharpe Ratio Comparison

The current VCYT Sharpe Ratio is 1.76, which is higher than the RBRK Sharpe Ratio of -0.03. The chart below compares the historical Sharpe Ratios of VCYT and RBRK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

VCYT vs. RBRK - Drawdown Comparison

The maximum VCYT drawdown since its inception was -81.19%, which is greater than RBRK's maximum drawdown of -56.08%. Use the drawdown chart below to compare losses from any high point for VCYT and RBRK.

Drawdown Indicators

	VCYT	RBRK	Difference
Max Drawdown Largest peak-to-trough decline	-81.19%	-56.08%	-25.11%
Max Drawdown (1Y) Largest decline over 1 year	-39.23%	-55.52%	+16.29%
Max Drawdown (3Y) Largest decline over 3 years	-50.09%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-71.54%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-81.19%	—	—
Current Drawdown Current decline from peak	-30.00%	-15.40%	-14.60%
Average Drawdown Average peak-to-trough decline	-48.23%	-19.00%	-29.23%
Ulcer Index Depth and duration of drawdowns from previous peaks	17.95%	30.92%	-12.97%

Volatility

VCYT vs. RBRK - Volatility Comparison

The current volatility for Veracyte, Inc. (VCYT) is 14.02%, while Rubrik, Inc. (RBRK) has a volatility of 14.97%. This indicates that VCYT experiences smaller price fluctuations and is considered to be less risky than RBRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VCYT	RBRK	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.02%	14.97%	-0.95%
Volatility (6M) Calculated over the trailing 6-month period	40.81%	45.30%	-4.49%
Volatility (1Y) Calculated over the trailing 1-year period	61.17%	62.97%	-1.80%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	64.51%	63.83%	+0.68%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	62.09%	63.83%	-1.74%

Dividends

VCYT vs. RBRK - Dividend Comparison

Neither VCYT nor RBRK has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

VCYT vs. RBRK - Profitability Comparison

The chart below illustrates the profitability comparison between Veracyte, Inc. and Rubrik, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

VCYT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Veracyte, Inc. reported a gross profit of 101.16M and revenue of 139.07M. Therefore, the gross margin over that period was 72.7%.

RBRK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Rubrik, Inc. reported a gross profit of 311.78M and revenue of 387.07M. Therefore, the gross margin over that period was 80.6%.

VCYT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Veracyte, Inc. reported an operating income of 22.65M and revenue of 139.07M, resulting in an operating margin of 16.3%.

RBRK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Rubrik, Inc. reported an operating income of -52.63M and revenue of 387.07M, resulting in an operating margin of -13.6%.

VCYT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Veracyte, Inc. reported a net income of 28.71M and revenue of 139.07M, resulting in a net margin of 20.6%.

RBRK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Rubrik, Inc. reported a net income of -41.85M and revenue of 387.07M, resulting in a net margin of -10.8%.

Frequently Asked Questions

Can I hold both VCYT and RBRK in my portfolio?

VCYT and RBRK have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VCYT or RBRK?

RBRK has higher volatility (14.97%) compared to VCYT (14.02%). In terms of maximum drawdown, VCYT dropped -81.19% vs RBRK's -56.08%.

Which has better risk-adjusted returns?

VCYT currently has the higher Sharpe Ratio (1.76 vs -0.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.